Wiebe C et al. |
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. |
2017 |
J. Am. Soc. Nephrol. |
pmid:28729289
|
Wu Z et al. |
FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients. |
2017 |
Eur. J. Clin. Pharmacol. |
pmid:27747372
|
Nakagawa K et al. |
Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures. |
2017 |
Am. J. Reprod. Immunol. |
pmid:28466977
|
Harada S et al. |
Complete remission of angiolymphoid hyperplasia with eosinophilia using topical tacrolimus. |
2017 |
Eur J Dermatol |
pmid:28007668
|
Cui W et al. |
Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy. |
2017 |
Braz. J. Med. Biol. Res. |
pmid:28355356
|
Vanhove T et al. |
Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28168728
|
Dong Y et al. |
Risk Factors, Clinical Features, and Treatment Outcomes of Recurrent Mooren Ulcers in China. |
2017 |
Cornea |
pmid:28060068
|
Dutta D et al. |
Recruitment of calcineurin to the TCR positively regulates T cell activation. |
2017 |
Nat. Immunol. |
pmid:27941787
|
Naicker D et al. |
Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients. |
2017 |
Pediatr. Nephrol. |
pmid:28660366
|
Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Nakamura K et al. |
Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model. |
2018 |
Transpl. Immunol. |
pmid:28988984
|
Ixtlapale-Carmona X et al. |
Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies. |
2018 |
Transpl. Immunol. |
pmid:28974434
|
Felipe C et al. |
Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients. |
2018 |
Ther Drug Monit |
pmid:29271815
|
Kimura Y et al. |
Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. |
2018 |
Arch. Toxicol. |
pmid:29594315
|
Sablik KA et al. |
Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection. |
2018 |
PLoS ONE |
pmid:29746495
|
Thishya K et al. |
Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation. |
2018 |
PLoS ONE |
pmid:29621269
|
Goto T et al. |
Prospective observational study on the first 51 cases of peripheral blood stem cell transplantation from unrelated donors in Japan. |
2018 |
Int. J. Hematol. |
pmid:29027623
|
Liu J et al. |
Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients. |
2018 |
Int. Immunopharmacol. |
pmid:29454235
|
Yoon CH et al. |
Topical Tacrolimus 0.03% for Maintenance Therapy in Steroid-Dependent, Recurrent Phlyctenular Keratoconjunctivitis. |
2018 |
Cornea |
pmid:29309358
|
Buchholz BM et al. |
Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients. |
2018 |
World J. Gastroenterol. |
pmid:30065563
|